We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
57 hedge funds and large institutions have $23.8M invested in Anavex Life Sciences in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 15
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
2% less funds holding
Funds holding: 58 → 57 (-1)
2.71% less ownership
Funds ownership: 23.07% → 20.36% (-2.7%)
16% less capital invested
Capital invested by funds: $28.4M → $23.8M (-$4.55M)
79% less call options, than puts
Call options by funds: $195K | Put options by funds: $926K
Holders
57
Holders Change
-1
Holders Change %
-1.72%
% of All Funds
1.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
15
Reduced
15
Closed
16
Calls
$195K
Puts
$926K
Net Calls
-$731K
Net Calls Change
-$177K
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.87M |
| 2 |
Goldman Sachs
New York
|
+$791K |
| 3 |
ECM
Element Capital Management
New York
|
+$561K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$535K |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$477K |
Top Sellers
| 1 |
BlackRock
New York
|
-$4.39M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.66M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$944K |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$292K |
| 5 |
Bank of New York Mellon
New York
|
-$256K |
